Alan Mishra, the professor of orthopedic surgery at Stanford University Medical Center, has developed an experimental treatment that encourages the body to heal wounds quickly and effectively. The experiment, if successful, can bring an end to the very common and devastating problem especially in life of a sportsman, tennis elbow.
The technique, called platelet-rich plasma (PRP) treatment, works by drawing blood from a patient and running it through a centrifuge, distilling the blood to a platelet concentration level five times as rich as regular blood. That plasma is then injected into the damaged tendon or muscle, overloading the area with healing cells and encouraging natural repair.
The treatment is likely to be more popular than the traditional surgical procedure. As a reason, there is the time factor. In traditional surgery, the players have to take time for rehab. It can range upto one year. Also the traditional surgery can cost anything $25,000. A player have to pay the money while she is not playing and winning tournament prize money.
The PRP trials are going on and have not received the FDA approval yet. More tests are needed before PRP is ready to undergo the FDA approval process, but the treatment has already become a worldwide subject of research. The treatment, is a not a silver bullet, that can replace surgery for the most severe tears. But it’s an attractive alternative, due to its shorter recovery time and lower risk of causing further career-ending damage.